TWi Biotechnology, Inc. (TPEX:6610)

TWi Biotechnology Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 24, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,110	1,223	1,229	1,007	1,089	1,015
Market Cap Growth	81.69%	-0.52%	22.02%	-7.50%	7.31%	72.00%
Enterprise Value	1,781	999	1,108	821	914	704
Last Close Price	19.60	13.95	14.00	14.26	15.51	14.45
PS Ratio	-	-	-	-	16.40	814.52
PB Ratio	7.85	6.95	3.60	4.89	3.91	3.45
P/TBV Ratio	8.84	8.57	4.07	6.27	4.80	4.31
EV/Sales Ratio	-	-	-	-	13.76	565.35
Debt / Equity Ratio	0.02	0.09	0.02	0.01	0.02	0.03
Net Debt / Equity Ratio	-1.22	-0.72	-0.93	-0.77	-0.78	-0.70
Net Debt / EBITDA Ratio	2.23	0.74	1.95	1.92	32.46	2.29
Net Debt / FCF Ratio	2.51	0.82	2.35	2.62	6.29	3.27
Asset Turnover	-	-	-	-	0.19	0.00
Inventory Turnover	-	-	-	-	-	0.41
Quick Ratio	2.77	2.36	6.83	6.28	8.43	2.48
Current Ratio	2.78	2.93	6.85	6.32	8.49	2.52
Return on Equity (ROE)	-60.59%	-63.77%	-62.41%	-31.43%	-5.34%	-29.52%
Return on Assets (ROA)	-27.83%	-34.91%	-33.58%	-20.67%	-2.74%	-15.10%
Return on Capital Employed (ROCE)	-56.50%	-98.30%	-48.50%	-43.20%	-5.40%	-32.70%
Earnings Yield	-7.36%	-13.48%	-13.89%	-7.56%	-1.41%	-10.04%
FCF Yield	-6.21%	-12.74%	-10.92%	-5.98%	-3.19%	-6.17%
Buyback Yield / Dilution	-5.63%	-19.75%	-8.52%	-	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.